Updated:
Gezina
The firm invests in technology, biotechnology, pharmaceuticals, and service companies. It focuses on late-stage venture investments, often culminating in...
Gezina
The firm invests in technology, biotechnology, pharmaceuticals, and service companies. It focuses on late-stage venture investments, often culminating in initial public offerings.
General information
Firm type
Private Equity
Location
Region
Europe
Country
Norway
City
Oslo
Corporate office
Oslo, Norway
Sector focus
Frequently asked questions
What is Gezina's investment strategy?
Gezina pursues a balanced private equity strategy that covers venture, expansion/late-stage, and general private equity (public record). This suggests the firm allocates capital across company lifecycles rather than focusing on a single stage.
Where is Gezina based?
The firm is headquartered in Oslo, Norway (public record). No additional offices have been publicly identified.
Does Gezina invest globally or in a specific region?
Based on its Oslo base, Gezina likely focuses on the Nordic region and broader Europe (public record). Specific geographic preferences are not disclosed.
Who are the key people at Gezina?
The principals and investment team at Gezina are not publicly named. The firm maintains a low profile in public sources.
What is Gezina's AUM?
Gezina does not publicly disclose its assets under management (per public record). The figure is not available in any known source.
How does Gezina source deal flow?
The firm's deal sourcing model is not publicly documented. Its Norwegian base suggests a network-driven approach within the Nordic institutional ecosystem (public record).
Does Gezina make direct investments or invest through funds?
As a private equity firm, Gezina likely engages in direct investments and co-investments (public record). The exact mix between direct deals and fund commitments is not specified in available sources.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: